EcoDrugPlus

Transthyretin

Ensembl ID : ENSBMSG00010014822
Gene Symbol: TTR
1 Cross references
165 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSBMSG00010012841
Gene Symbol: TPH1
1 Cross references
257 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSBMSG00010017602
Gene Symbol: TUBA1C
1 Cross references
184 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSBMSG00010001061
Gene Symbol: TUBA4A
1 Cross references
225 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSBMSG00010012204
Gene Symbol: TUBB1
1 Cross references
186 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSBMSG00010007239
Gene Symbol: TUBB2A
1 Cross references
228 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSBMSG00010002735
Gene Symbol: TUBB4A
1 Cross references
89 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSBMSG00010003932
Gene Symbol: TUBB4B
1 Cross references
178 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSBMSG00010019797
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSBMSG00010013877
Gene Symbol: TUBB
1 Cross references
114 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSBMSG00010015103
Gene Symbol: TP53
1 Cross references
254 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSBMSG00010001331
Gene Symbol: TYR
1 Cross references
266 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).